Hjärup, Sweden

Magnus Jöud

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Lu License Ab. Active years: 2018-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Magnus Jöud. Retrieved from https://idiyas.com/inventor/magnus-jöud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Magnus Jöud in Blood Group Typing

Introduction

Magnus Jöud is an accomplished inventor based in Hjärup, Sweden. He has made significant contributions to the field of blood group typing, particularly focusing on the Vel blood group. With a total of 2 patents, his work is crucial for ensuring safe blood transfusions.

Latest Patents

Magnus Jöud's latest patents include innovative methods and tools for Vel blood group typing. The first patent relates to methods and tools for discriminating between Vel negative and Vel positive phenotypes. This invention is particularly useful for determining the Vel blood group status of individuals who are about to receive blood transfusions. The second patent mirrors the first, emphasizing the importance of accurate blood group typing in medical settings.

Career Highlights

Magnus Jöud is currently associated with Lu License AB, where he continues to develop and refine his inventions. His expertise in blood group typing has positioned him as a key figure in this specialized area of research.

Collaborations

Some of his notable coworkers include Jill R Storry and Björn Nilsson, who contribute to the collaborative efforts in advancing blood typing technologies.

Conclusion

Magnus Jöud's innovations in blood group typing are vital for enhancing the safety and efficacy of blood transfusions. His patents reflect a commitment to improving medical practices and patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…